YEEDOZENCOM

YeeDozen is a South Korean biotechnology company specializing in AI-driven drug discovery for rare and intractable diseases. The company utilizes its proprietary YeeDozen-AI platform to integrate multi-omics data and identify novel therapeutic targets and drug candidates. By focusing on high-unmet-need areas such as oncology and rare genetic disorders, YeeDozen aims to significantly shorten the drug development lifecycle. The firm maintains strategic collaborations with major medical institutions to validate its computational findings through clinical data. YeeDozen is positioned as an emerging leader in the South Korean digital health and biotech ecosystem.